Independent and combined effects of depressive symptoms and cardiometabolic risk factors on dementia incidence: a cross-country comparison in England, the United States and China
Panagiota Kontari , Chris Fife-Schaw , Kimberley Smith
{"title":"Independent and combined effects of depressive symptoms and cardiometabolic risk factors on dementia incidence: a cross-country comparison in England, the United States and China","authors":"Panagiota Kontari , Chris Fife-Schaw , Kimberley Smith","doi":"10.1016/j.archger.2025.105889","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Depression and cardiometabolic conditions are suggested as modifiable risk factors for dementia, yet their combined impact remains unclear. This study assessed the independent and combined effects of depressive symptoms and cardiometabolic conditions on dementia incidence in England, the US and China.</div></div><div><h3>Methods</h3><div>The sample comprised 4472 participants aged 50 and older from the English Longitudinal Study of Ageing (ELSA), 5021 from Health and Retirement Study (HRS), and 8925 from China Health and Retirement Longitudinal Study (CHARLS). Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression scale. Cardiometabolic factors included central obesity, low high‐density-lipoprotein (HDL) cholesterol, systolic and diastolic blood pressure (BP), hyperglycemia, diabetes, and inflammation. Dementia incidence was estimated using confounder-adjusted Cox proportional hazards regressions, and pooled estimates were obtained using random-effects meta-analysis.</div></div><div><h3>Results</h3><div>A total of 1218 individuals developed dementia over a median of 6.8–12.2 years. Depressive symptoms (ELSA: <em>HR =</em> 1.47 [95 % CI = 1.09–2.00]; HRS: <em>HR =</em> 1.68 [95 % CI = 1.33–2.13]; CHARLS: <em>HR =</em> 1.35 [95 % CI = 1.12–1.64]) and elevated systolic BP (ELSA: <em>HR =</em> 1.51 [95 % CI = 1.17–1.95]; HRS: <em>HR =</em> 1.48 [95 % CI = 1.24–1.79]; CHARLS: <em>HR =</em> 1.26 [95 % CI = 1.05–1.52]) were linked to dementia risk in all countries. While cardiometabolic multimorbidity (≥2 conditions) was not associated with dementia risk, those with the highest cardiometabolic index (≥4 conditions) had a greater risk of dementia in all samples (ELSA: <em>HR =</em> 1.82 [95 % CI = 1.01–3.26]; HRS: <em>HR =</em> 1.85 [95 % CI = 1.02–3.35]; CHARLS: <em>HR =</em> 1.65 [95 % CI = 1.18–2.30]).</div></div><div><h3>Conclusion</h3><div>Depressive symptoms are independently linked to dementia risk, while having multiple cardiometabolic conditions further increases this risk, especially when co-occurring with depressive symptoms in both Western and Chinese populations.</div></div>","PeriodicalId":8306,"journal":{"name":"Archives of gerontology and geriatrics","volume":"136 ","pages":"Article 105889"},"PeriodicalIF":3.5000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of gerontology and geriatrics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167494325001463","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Depression and cardiometabolic conditions are suggested as modifiable risk factors for dementia, yet their combined impact remains unclear. This study assessed the independent and combined effects of depressive symptoms and cardiometabolic conditions on dementia incidence in England, the US and China.
Methods
The sample comprised 4472 participants aged 50 and older from the English Longitudinal Study of Ageing (ELSA), 5021 from Health and Retirement Study (HRS), and 8925 from China Health and Retirement Longitudinal Study (CHARLS). Depressive symptoms were assessed using the Center for Epidemiological Studies-Depression scale. Cardiometabolic factors included central obesity, low high‐density-lipoprotein (HDL) cholesterol, systolic and diastolic blood pressure (BP), hyperglycemia, diabetes, and inflammation. Dementia incidence was estimated using confounder-adjusted Cox proportional hazards regressions, and pooled estimates were obtained using random-effects meta-analysis.
Results
A total of 1218 individuals developed dementia over a median of 6.8–12.2 years. Depressive symptoms (ELSA: HR = 1.47 [95 % CI = 1.09–2.00]; HRS: HR = 1.68 [95 % CI = 1.33–2.13]; CHARLS: HR = 1.35 [95 % CI = 1.12–1.64]) and elevated systolic BP (ELSA: HR = 1.51 [95 % CI = 1.17–1.95]; HRS: HR = 1.48 [95 % CI = 1.24–1.79]; CHARLS: HR = 1.26 [95 % CI = 1.05–1.52]) were linked to dementia risk in all countries. While cardiometabolic multimorbidity (≥2 conditions) was not associated with dementia risk, those with the highest cardiometabolic index (≥4 conditions) had a greater risk of dementia in all samples (ELSA: HR = 1.82 [95 % CI = 1.01–3.26]; HRS: HR = 1.85 [95 % CI = 1.02–3.35]; CHARLS: HR = 1.65 [95 % CI = 1.18–2.30]).
Conclusion
Depressive symptoms are independently linked to dementia risk, while having multiple cardiometabolic conditions further increases this risk, especially when co-occurring with depressive symptoms in both Western and Chinese populations.
期刊介绍:
Archives of Gerontology and Geriatrics provides a medium for the publication of papers from the fields of experimental gerontology and clinical and social geriatrics. The principal aim of the journal is to facilitate the exchange of information between specialists in these three fields of gerontological research. Experimental papers dealing with the basic mechanisms of aging at molecular, cellular, tissue or organ levels will be published.
Clinical papers will be accepted if they provide sufficiently new information or are of fundamental importance for the knowledge of human aging. Purely descriptive clinical papers will be accepted only if the results permit further interpretation. Papers dealing with anti-aging pharmacological preparations in humans are welcome. Papers on the social aspects of geriatrics will be accepted if they are of general interest regarding the epidemiology of aging and the efficiency and working methods of the social organizations for the health care of the elderly.